Our data clearly indicated, that such dependence on the metastatic CRC phenotype wasn't given, there were no observed differences measured between EpCAM+ or EpCAM+CD147+ taMPs isolated from metastatic CRC patients samples or non metastatic CRC samples (Figure 3C–3D). This evidence concerns the gene EPCAM and colorectal carcinoma.